Söderholm, Jonas http://orcid.org/0000-0002-7810-3005
Yilmaz, Aylin
Svenningsson, Anders http://orcid.org/0000-0003-0663-2220
Büsch, Katharina
Wejstål, Rune
Brolund, Alma
Kövamees, Jan
Sällberg, Matti
Lagging, Martin http://orcid.org/0000-0002-7995-3626
Gisslén, Magnus
Article History
Received: 13 February 2019
Revised: 13 May 2019
Accepted: 22 May 2019
First Online: 31 May 2019
Compliance with ethical standards
:
: ML is a consultant for AbbVie, BMS, Gilead, Medivir, and MSD/Merck, and is a member of the speakers’ bureaus for AbbVie, BMS, Gilead, Medivir, and MSD/Merck. MG has received research grants from Gilead Sciences and received honoraria as speaker and/or scientific advisor from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Janssen-Cilag, and MSD. MS is founder and owner of Svenska Vaccinfabriken AB. RW has received consultant fees from AbbVie for medical advisory board and teaching. AY has received lecture fees from Gilead, Janssen, and AbbVie. AS have nothing to disclose. JS, JK, and KB are employees of AbbVie and may hold AbbVie stocks or stock options. AB is a former employee of AbbVie and may hold AbbVie stocks or stock options.
: The study was approved by the Stockholm Regional Ethics Committee at Karolinska Institutet (Sweden) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.